The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia.

The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...

VIENNA--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug ...

Pulsed field ablation (PFA) has gained attention in cardiac electrophysiology, but data on its application to paroxysmal supraventricular tachycardia are limited. This study aimed to assess the ...

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

The S1 heart sound is two of your heart valves closing. It's the first sound doctors can hear with a stethoscope. Learn what ...

Stereotaxis' holistic ecosystem approach aims to solve long-standing issues with robotic adoption in EP. See why STXS stock ...

Heart palpitations or fast heartbeats can suddenly become more noticeable when you feel like your heart has skipped a beat, ...

China: A recent clinical trial has demonstrated that partial cardiac denervation (pCAD) is an effective strategy for reducing ...

Cain, 59, swindled $400 million from hundreds of investors in a Ponzi scheme and was jailed for 15 years in and shipped off ...

After hours: November 29 at 3:35 PM EST Loading Chart for MIST ...